Eurofins Scientific Nante (ERFSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 600,133 | 458,138 | 821,808 | 1,250,063 | 793,213 |
| Depreciation Amortization | 645,906 | 611,500 | 531,436 | 533,223 | 486,620 |
| Accounts receivable | 30,082 | -21,646 | -1,580 | -122,214 | -157,409 |
| Accounts payable and accrued liabilities | -28,026 | -44,699 | 21,177 | 101,273 | 151,012 |
| Other Working Capital | 47,504 | -70,025 | 32,872 | -6,152 | -55,287 |
| Other Operating Activity | 131,584 | 168,406 | -208,507 | 30,051 | 179,455 |
| Operating Cash Flow | $1,427,182 | $1,101,673 | $1,197,206 | $1,786,244 | $1,397,604 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,571 | 2,056 | 1,580 | -9,938 | -114 |
| PPE Investments | -479,803 | -510,521 | -591,280 | -511,927 | -349,087 |
| Net Acquisitions | -372,567 | -163,211 | -226,208 | -630,237 | -202,416 |
| Purchase Sale Intangibles | -80,941 | -77,926 | -88,608 | -73,352 | -51,061 |
| Other Investing Activity | -60,057 | -65,479 | -85,868 | -71,459 | -48,091 |
| Investing Cash Flow | $-915,998 | $-737,155 | $-901,776 | $-1,223,562 | $-599,708 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 127,688 | 691,049 | 667,877 | 977,596 | 1,080,844 |
| Debt Repayment | -516,919 | -97,407 | -87,343 | -1,514,368 | -1,490,130 |
| Common Stock Issued | 216 | 651,004 | 15,383 | 42,355 | 645,171 |
| Common Stock Repurchased | -294,223 | -60,392 | -16,647 | -4,259 | N/A |
| Dividend Paid | -106,046 | -208,992 | -202,818 | -154,276 | -571 |
| Other Financing Activity | -389,664 | -527,621 | -704,437 | -424,023 | -290,830 |
| Financing Cash Flow | $-1,178,948 | $447,639 | $-327,986 | $-1,076,976 | $-55,516 |
| Exchange Rate Effect | 10,172 | -13,745 | -843 | 46,259 | -38,724 |
| Beginning Cash Position | 1,321,136 | 522,967 | 542,604 | 1,077,213 | 336,407 |
| End Cash Position | 663,544 | 1,321,380 | 509,100 | 609,297 | 1,040,064 |
| Net Cash Flow | $-657,592 | $798,521 | $-33,505 | $-467,916 | $703,657 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,427,182 | 1,101,673 | 1,197,206 | 1,786,244 | 1,397,604 |
| Capital Expenditure | -490,841 | -517,448 | -606,979 | -541,268 | -355,027 |
| Free Cash Flow | 936,342 | 584,225 | 590,227 | 1,244,976 | 1,042,577 |